The latest analyst work on Evolus keeps the modeled fair value steady at US$14.67 per share, even as several firms reduce their published price targets. Those cuts are tied less to a change in the core valuation inputs and more to how analysts interpret the softer preliminary 2025 net revenue outlook, the 2026 guide, and the scaled back long term narrative. As you read on, you will see how to approach this evolving setup and what to watch as the story continues to develop. Stay updated as the...
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
150last 24h
876last 7d
146● bullish (7d)
96● bearish (7d)
214publishers
Simply Wall St.166d agobearish
How The Evolus (EOLS) Investment Story Is Shifting After Softer Guidance And Target Cuts